Vergoeding 2017-2021 voor ATC-subgroep N03AX : Overige anti-epileptica

  • Raming voor de totale Zvw-populatie
  2017 2018 2019 2020 2021
N03AX09 Lamotrigine (Lamictal ®) 2.435.300 2.692.800 2.755.100 3.045.300 3.414.900
N03AX10 Felbamaat (Taloxa ®) 132.320 118.920 118.360 122.180 104.930
N03AX11 Topiramaat (Topamax ®) 905.010 1.107.300 1.297.500 1.433.700 1.444.200
N03AX12 Gabapentine (Neurontin ®) 1.388.300 1.584.900 1.875.600 1.948.400 2.133.100
N03AX14 Levetiracetam (Keppra ®) 4.735.900 5.208.800 5.187.500 6.781.300 7.088.700
N03AX15 Zonisamide (Zonegran ®) 438.840 383.930 367.090 371.670 365.730
N03AX16 Pregabaline (Lyrica ®) 23.870.500 9.328.700 8.463.000 9.089.800 7.480.400
N03AX17 Stiripentol (Diacomit ®) 450.470 451.630 423.970 410.690 419.460
N03AX18 Lacosamide (Vimpat ®) 3.569.500 4.198.300 4.920.600 5.480.400 5.513.700
N03AX21 Retigabine 1.488 . . . .
N03AX22 Perampanel (Fycompa ®) 547.980 593.370 676.250 754.020 817.630
N03AX23 Brivaracetam (Briviact ®) 436.800 950.000 1.657.400 2.217.300 2.882.700
Totaal 38.912.408 26.618.650 27.742.370 31.654.760 31.665.450